From exome analysis in idiopathic azoospermia to the identification of a high-risk subgroup for occult Fanconi anemia

Purpose: in about 10% of patients affected by Fanconi anemia (FA) the diagnosis is delayed until adulthood, and the presenting symptom in these "occult" FA cases is often a solid cancer and cancer treatment-related toxicity. Highly predictive clinical parameter(s) for diagnosing such an ad...

Descripción completa

Detalles Bibliográficos
Autores: Krausz, Csilla|||0000-0001-6748-8918, Riera-Escamilla, Antoni|||0000-0002-4485-3094, Chianese, Chiara|||0000-0002-8952-0584, Moreno-Mendoza, Daniel, Ars, Elisabet|||0000-0002-4118-4358, Rajmil Marquenson, Osvlado|||0000-0003-1987-9206, Pujol Calvet, Maria Roser|||0000-0003-1840-5455, Bogliolo, Massimo|||0000-0001-8240-7784, Blanco Guillermo, Ignacio|||0000-0002-7414-7481, Rodríguez, Inés, Badell Serra, Isabel|||0000-0001-6546-2175, Ruiz-Castañé, Eduardo|||0000-0002-7469-4610, Surralles, Jordi|||0000-0002-4041-7519
Tipo de recurso: artículo
Fecha de publicación:2019
País:España
Institución:Universitat Autònoma de Barcelona
Repositorio:Dipòsit Digital de Documents de la UAB
Idioma:inglés
OAI Identifier:oai:ddd.uab.cat:197194
Acceso en línea:https://ddd.uab.cat/record/197194
https://dx.doi.org/urn:doi:10.1038/s41436-018-0037-1
Access Level:acceso abierto
Palabra clave:Azoospermia
Exome sequencing
Fanconi anemia
Genetics
Male infertility
Descripción
Sumario:Purpose: in about 10% of patients affected by Fanconi anemia (FA) the diagnosis is delayed until adulthood, and the presenting symptom in these "occult" FA cases is often a solid cancer and cancer treatment-related toxicity. Highly predictive clinical parameter(s) for diagnosing such an adult-onset cases are missing. - Methods: (1) Exome sequencing (ES), (2) Sanger sequencing of FANCA, (3) diepoxybutane (DEB)-induced chromosome breakage test. - Results: ES identified a pathogenic homozygous FANCA variant in a patient affected by Sertoli cell-only syndrome (SCOS) and in his azoospermic brother. Although they had no overt anemia, chromosomal breakage test revealed a reverse somatic mosaicism in the former and a typical FA picture in the latter. In 27 selected SCOS cases, 1 additional patient showing compound heterozygous pathogenic FANCA variants was identified with positive chromosomal breakage test. - Conclusion: we report an extraordinarily high frequency of FA in a specific subgroup of azoospermic patients (7.1%). The screening for FANCA pathogenic variants in such patients has the potential to identify undiagnosed FA before the appearance of other severe clinical manifestations of the disease. The definition of this high-risk group for "occult" FA, based on specific testis phenotype with mild/borderline hematological alterations, is of unforeseen clinical relevance.